NT5E and neoplasm: Furthermore, targeting other signaling pathways that regulate CD73 expression, such as the CREB pathway activated by tumor-derived factors like PGE2, provides another therapeutic avenue to inhibit the immunosuppressive functions of MDSCs 146.